BLOG

Nonclinical study of JAK1-siRNA in minipigs shows targeted, long-lasting efficacy for inflammatory skin diseases with minimal systemic exposure.

Discover translational pharmacology strategies from industry expert to improve target validation, PK/PD understanding, and animal-to-human translation in early-phase drug development.

Kimberly Worley shares her STEM journey, highlighting mentorship, diversity, and how empowering girls strengthens innovation and the future of science.

Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.

We invited several of our Altascientists to share insights into their career journeys in the life sciences and their perspectives on the future of the field.

Ken Phares demystifies ICH Q14 & Q2(R2) guidelines with practical strategies for analytical procedure development, risk-based method design, and lifecycle management.

Discover how clinic-ready manufacturing and adaptive clinical trials streamline drug development, prevent delays, conserve your resources, and ensure safety, compliance, and efficiency.